WallStSmart
AURA

Aura Biosciences Inc

NASDAQ: AURA · HEALTHCARE · BIOTECHNOLOGY

$7.05
+4.75% today

Updated 2026-04-30

Market cap
$432.06M
P/E ratio
P/S ratio
EPS (TTM)
$-1.76
Dividend yield
52W range
$4 – $8
Volume
0.3M

Aura Biosciences Inc (AURA) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+3.3%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+28.8%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+3.7%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+8.1%
2026-03-31
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-31$-0.37+14.8%$6.20$6.70+8.1%
2025-11-13$-0.40+13.0%$5.57$5.53-0.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.43$-0.37+14.8%
2025-09-30$-0.46$-0.40+13.0%
2025-06-30$-0.47$-0.47+0.0%
2025-03-31$-0.48$-0.55-14.6%
2024-12-31$-0.44$-0.52-18.2%$1.24M-39.8%
2024-09-30$-0.44$-0.42+4.5%
2024-06-30$-0.45$-0.41+8.9%
2024-03-31$-0.49$-0.40+18.4%$2.06M
2023-12-31$-0.41$-0.56-36.6%$2.06M
2023-09-30$-0.52$-0.48+7.7%
2023-06-30$-0.49$-0.48+2.0%
2023-03-31$-0.54$-0.46+14.8%

Frequently asked questions

Has Aura Biosciences Inc beaten earnings estimates?
Aura Biosciences Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +3.3% over the last 4 quarters.
How does AURA stock react to earnings?
AURA stock has moved an average of +3.7% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.